1 completed, 1 recruiting, 1 unknown. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 1, Recruiting 1, Unknown 1 |
Follow iNKT Cells: new trials by email Literature Review of iNKT Cells trials Research Report on iNKT Cells
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| GKL-006 Injection Plus TACE Versus TACE Alone in Patients With Unresectable Hepatocellular Carcinoma GKL-006 Injection, TACE - Hepatocellular Carcinoma (HCC), Unresectable Hepatocellular Cancer | Phase 2 | Recruiting | Beijing Gene Key Life Technology Co., Ltd | 48 | 2025-11-14 | 2026-08-17 |
| Adoptive Autologous iNKT Cells for the Treatment of Progressed Hepatocellular Carcinoma Continuing on PD-1 Inhibitor Therapy iNKT Cells, PD-1, Regorafenib - Hepatocellular Carcinoma | Phase 2 | Unknown | Beijing YouAn Hospital | 84 | 2023-10-26 | 2024-01-16 |
| Study of Adoptive Transfer of iNKT Cells Combined With TAE/TACE to Treat Unresectable HCC iNKT cells, Human recombinated Interleukin-2, TAE/TACE - Hepatocellular Carcinoma | Phase 2 | Completed | Beijing YouAn Hospital | 60 | 2018-03-01 | 2024-10-08 |
Beijing YouAn Hospital (2) · Beijing Gene Key Life Technology Co., Ltd (1)
China (3)
Gaojun Teng, MD (1) · Jun Lu, Director (1) · Jun Lu, MD. (1)